#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Short stature Renal cancer metastatic Pleomorphic liposarcoma Metabolic disorder Hyperadrenocorticism Kearns-Sayre syndrome Immune-mediated myasthenia gravis Prodromal Alzheimer's disease Chronic graft versus host disease in liver Crigler-Najjar syndrome Haemophagocytic lymphohistiocytosis Glycogen storage disease type II Small intestine adenocarcinoma Cortical dysplasia Epilepsy More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Treatment Skin angiosarcoma – Treatment Krabbe’s disease – Trials in Disease Activated PI3 kinase delta syndrome – Diagnostics Vascular malformation – Life with Disease Nodal marginal zone B-cell lymphoma – Diagnostics Lymphatic malformation – Treatment Splenic marginal zone lymphoma – Diagnostics Kearns-Sayre syndrome – Life with Disease Fabry’s disease – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefazolin Ruzasvir Nizaracianine Triflutate Ceftolozane Edoxaban Bromhexine Hydrochloride ICEF15 Sodium Lactate GSKVX000000030810 Enoxaparin Sodium Corticosteroids, Plain Dexamethasone Ciclosporin Cyanocobalamin Anhydrous Cidofovir Nido-361 Vsf1.01 Cladribine GOLD SODIUM THIOSULFATE Deferoxamine More therapies…

    Learn about Your Condition

    Gastric cancer stage IV Amyotrophic lateral sclerosis Embolism Fibromyalgia Endocarditis enterococcal Exfoliation glaucoma Inborn error of metabolism Chronic hepatic failure Hypogonadism male Penile squamous cell carcinoma Eye disorder Spinal osteoarthritis Conjunctivitis allergic Chronic spontaneous urticaria Intervertebral disc protrusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bulevard Vasil Aprilov 15a, Plovdiv, 4002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapagliflozin Propanediol
    • Metformin Embonate
    Bulgaria Croatia Germany Greece Hungary Poland +3

  • Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Breast cancer
    • Cervix carcinoma recurrent
    • Cholangiocarcinoma
    Investigated Drugs:
    • Bemarituzumab
    Austria Belgium Bulgaria Czechia Denmark Finland +9

  • Comparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Enoxaparin Sodium
    • SRSD107
    Bulgaria Czechia Hungary Latvia Lithuania Poland

  • Study comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Ublituximab
    Bulgaria Croatia Czechia Hungary

  • Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Bulgaria Czechia Germany Hungary Poland Slovakia +1

  • Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

    Not recruiting

    3 1
    Investigated Diseases:
    • Type IIa hyperlipidaemia
    Bulgaria Czechia Denmark Finland France Germany +6

  • Evaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation

    Not recruiting

    3 1
    Investigated Drugs:
    • Ziltivekimab
    Bulgaria Czechia France Germany Greece Poland +1

  • Long-Term Safety Study of Plozasiran for Adults with High Triglycerides

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study on BJT-778 for Patients with Chronic Hepatitis Delta Infection

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Bjt-778
    Bulgaria

  • Study on the Safety of a New Chickenpox Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Varicella
    Investigated Drugs:
    • GSKVX000000025896
    • VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED)
    • VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
    Bulgaria Denmark Estonia Lithuania Poland
Previous Page
1 … 9 10 11 12 13 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!